GCN1
Basic information
Region (hg38): 12:120127202-120194715
Previous symbols: [ "GCN1L1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GCN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | |||||
missense | 169 | 170 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 1 | |||||
Total | 0 | 0 | 169 | 8 | 6 |
Variants in GCN1
This is a list of pathogenic ClinVar variants found in the GCN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-120127853-G-A | not specified | Uncertain significance (Apr 19, 2025) | ||
12-120127880-G-A | not specified | Likely benign (Feb 03, 2025) | ||
12-120127886-T-A | not specified | Uncertain significance (Sep 23, 2023) | ||
12-120127889-G-A | not specified | Uncertain significance (Mar 23, 2023) | ||
12-120127916-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
12-120127919-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
12-120127971-G-A | not specified | Uncertain significance (Apr 01, 2025) | ||
12-120129300-C-T | not specified | Uncertain significance (Dec 02, 2024) | ||
12-120129313-T-C | not specified | Uncertain significance (Jun 05, 2023) | ||
12-120129329-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
12-120129359-C-T | not specified | Uncertain significance (Jan 08, 2025) | ||
12-120129364-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
12-120129374-G-T | not specified | Uncertain significance (Jan 01, 2025) | ||
12-120129447-C-T | not specified | Uncertain significance (Apr 19, 2025) | ||
12-120129482-G-T | not specified | Uncertain significance (Apr 15, 2025) | ||
12-120130651-C-T | not specified | Likely benign (Apr 06, 2025) | ||
12-120130663-A-G | not specified | Uncertain significance (Apr 14, 2025) | ||
12-120130664-A-G | Likely benign (Apr 01, 2022) | |||
12-120130674-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
12-120130696-C-T | not specified | Uncertain significance (Apr 18, 2024) | ||
12-120130750-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
12-120131192-G-A | not specified | Uncertain significance (Mar 15, 2025) | ||
12-120131240-C-T | not specified | Uncertain significance (May 16, 2023) | ||
12-120131241-C-T | not specified | Uncertain significance (Mar 25, 2025) | ||
12-120131262-C-A | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GCN1 | protein_coding | protein_coding | ENST00000300648 | 58 | 67507 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 1.87e-8 | 124774 | 0 | 46 | 124820 | 0.000184 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.44 | 1069 | 1.56e+3 | 0.684 | 0.0000960 | 17230 |
Missense in Polyphen | 318 | 581.67 | 0.5467 | 6292 | ||
Synonymous | -0.503 | 693 | 676 | 1.02 | 0.0000443 | 5612 |
Loss of Function | 9.03 | 18 | 128 | 0.140 | 0.00000667 | 1481 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000475 | 0.000409 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000279 | 0.000232 |
European (Non-Finnish) | 0.000241 | 0.000238 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a positive activator of the EIF2AK4/GCN2 protein kinase activity in response to amino acid starvation. Forms a complex with EIF2AK4/GCN2 on translating ribosomes; during this process, GCN1 seems to act as a chaperone to facilitate delivery of uncharged tRNAs that enter the A site of ribosomes to the tRNA- binding domain of EIF2AK4/GCN2, and hence stimulating EIF2AK4/GCN2 kinase activity. Participates in the repression of global protein synthesis and in gene-specific mRNA translation activation, such as the transcriptional activator ATF4, by promoting the EIF2AK4/GCN2-mediated phosphorylation of eukaryotic translation initiation factor 2 (eIF-2-alpha/EIF2S1) on 'Ser-52', and hence allowing ATF4-mediated reprogramming of amino acid biosynthetic gene expression to alleviate nutrient depletion. {ECO:0000250|UniProtKB:E9PVA8, ECO:0000250|UniProtKB:P33892}.;
Recessive Scores
- pRec
- 0.391
Intolerance Scores
- loftool
- rvis_EVS
- -3.77
- rvis_percentile_EVS
- 0.24
Haploinsufficiency Scores
- pHI
- 0.210
- hipred
- Y
- hipred_score
- 0.793
- ghis
- 0.625
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Gcn1l1
- Phenotype
Gene ontology
- Biological process
- translation;regulation of translation;positive regulation of kinase activity;cellular response to amino acid starvation;positive regulation of transcription from RNA polymerase II promoter in response to stress;regulation of protein kinase activity;cellular response to leucine starvation
- Cellular component
- cytoplasm;cytosol;ribosome;polysome;membrane
- Molecular function
- RNA binding;translation factor activity, RNA binding;protein kinase regulator activity;protein kinase binding;ribosome binding;cadherin binding